Recent developments in cervical cancer screening, including the approval of a DNA-based HPV test as a stand-alone method for screening, has stirred debate on whether the Pap test should remain part of frontline cervical cancer screening.
PAP + HPV Co-Testing Increases Cevical Cancer Detection
Historically, the Papanicolaou (Pap) test was one of the most powerful weapons primarily responsible for the dramatic reduction in cervical cancer in the twentieth century. By the beginning of the twenty-first century, the combined use of Pap tests and high-risk human papillomavirus virus (HPV) based molecular assays contributed to a steady decline in the incidence of cervical cancer. However, recent developments in cervical cancer screening, including the approval of a DNA-based HPV test as a stand-alone method for screening, has stirred debate on whether the Pap test should remain part of frontline cervical cancer screening.
PCOS status linked to menopause age onset
March 28th 2024A recent regression model analysis unveils a 5% prolonged period to menopause in women with polycystic ovary syndrome, prompting further investigation into the condition's impact on reproductive health and the need for diverse longitudinal studies.
Read More
Study: Plant-based diets lower hypertensive disorders of pregnancy risk
March 28th 2024A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.
Read More